Although I was pleased to see yesterdays Chemeq announcement, I must admit I was initially disappointed, as to what had happened to that extra ordinary performance back in June 02 ie 17% weight gains and 11% less feed. These early thoughts of how can there now be such a difference, became clear when I reread the 02 announcement (see below) and realised that they were trials versus no treatment, whereas these latest trials are obviously against a major competitor. Needless to say, I am now more than happy. Warm regards, Ian
EXTRACTS ONLY OF THE FULL ASX NOTICE...DOUBLE CLICK ON LINK ABOVE TO SEE ALL.
* CHEMEQ® polymeric antimicrobial (for poultry), in comparison with the leading drug avilamycin, resulted in: * 51g per bird (2.5%) improvement in weight; * Reduction in feed requirement, i.e. a 0.08 (5%) reduction in Feed Conversion Ratio; * 25% reduction in mortality; * 26 points (9%) improvement on overall Performance Efficiency Factor
DETAILS OF THE COMMERCIAL TRIAL The details of the commercial trial to evaluate the commercial benefits of CHEMEQ® polymeric antimicrobial (for poultry) compared to avilamycin are as follows:
The birds were randomly allocated into one of two treatments: * CHEMEQ® polymeric antimicrobial (for poultry) (3 mg/kg/day for 39 days in water) * avilamycin (15 mg/kg feed for 39 days ) ==================================================================
EXTRACTS ONLY OF THE FULL ASX NOTICE...DOUBLE CLICK ON LINK ABOVE TO SEE ALL.
"Our earlier trials showed that higher doses of the drug gave healthier chickens, and hence weight gains," said Dr Murdoch. "However in this recent trial, the small dose of CHEMEQ(RTM) polymeric antimicrobial gave at least two outstanding benefits. Firstly, exceptional weight gain of 17%; and secondly, 11% less feed consumption whilst achieving this increase of weight. These results are most economically significant for poultry farmers."
The trial was independently directed by Professor David Hampson, using 60 broiler Cob 500 chickens, comparing the effect of CHEMEQ(RTM) polymeric antimicrobial (3mg/kg/day) versus no treatment, for 42 days. All results are statistically significant and, consistent with Chemeq Ltd's policy, are being prepared for publication in an international, peer-reviewed, scientific journal.
CMQ Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
